Abirakast 250mg Tablet
₹15990*
MRP ₹19500
18% off
₹16575*
MRP ₹19500
15% CB
₹2925 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Abirakast 250mg Tablet is an anti-androgen medicine used in the treatment of prostate cancer. It is used to treat metastatic castration-resistant prostate cancer (a condition where cancer does not get controlled with hormonal therapy) and metastatic castration-sensitive prostate cancer (a condition where cancer has spread to other parts of the body but can be controlled) in men. Prostate cancer is a condition that occurs when the prostate gland cells increase abnormally. Symptoms may include difficulty in urinating, pain, numbness, etc.
Abirakast 250mg Tablet contains Abiraterone acetate, which belongs to the class of androgen biosynthesis inhibitors. Testosterone is a natural hormone produced by the body. This causes an increase in cancer cells in the prostate gland. Abirakast 250mg Tablet works by inhibiting the production of the testosterone hormone and thus stops the growth and spread of cancer.
Abirakast 250mg Tablet may cause certain side effects such as nausea, dizziness, heartburn, headache, diarrhoea, muscle weakness, joint pain, confusion, hot flushes, loss of appetite and groin pain. These side effects usually disappear without any medical attention. However, if these side effects persist, inform your doctor. Take this medicine as advised by your doctor. It should be taken on an empty stomach at least 2 hours before or after meals. Your doctor will decide the dose of the medicine based on the severity of your disease.
Abirakast 250mg Tablet should be avoided if you are allergic to it. Inform your doctor if you have any pre-existing or a history of liver/kidney disease, cardiovascular disease, adrenocortical insufficiency, hypokalemia, hypoglycaemia, fluid retention before taking Abirakast 250mg Tablet. Abirakast 250mg Tablet is not recommended for use in women and children as the safety and efficacy of this medicine are not established. Inform your doctor of all your ongoing medications to avoid interactions. This medicine is used in combination with prednisolone for the treatment of prostate cancer.
Abirakast 250mg Tablet contains Abiraterone acetate, which belongs to the class of androgen biosynthesis inhibitors. Testosterone is a natural hormone produced by the body. This causes increase of cancer cells in prostate gland. Abirakast 250mg Tablet works by inhibiting the production of the testosterone hormone and thus stops the growth and spread of cancer. Abirakast 250mg Tablet is used in combination with prednisolone for the treatment of prostate cancer. It is mainly intended for use in men only.
Abirakast 250mg Tablet should be avoided if you are allergic to it or any other components present in it. Inform your doctor if you have/had any conditions like liver/kidney disease, cardiovascular disease, adrenocortical insufficiency, hypokalemia, hypoglycaemia, fluid retention or taking any other medicines before taking Abirakast 250mg Tablet as it may cause serious side effects. Abirakast 250mg Tablet is not recommended for use in women and children as the safety and efficacy of this medicine are not established. This medicine is used in combination with prednisolone for the treatment of prostate cancer.
Drug-drug interactions: Abirakast 250mg Tablet may interact with CYP3A4 Inducers (phenytoin, phenobarbital), CYP2D6 Substrates (Flecainide, Venlafaxine), antifungal medicine (ketoconazole, itraconazole), and many other medicines.
Drug-food interactions: No interactions found.
Drug-disease interactions: Abirakast 250mg Tablet should be used with caution in patients with severe liver and kidney failure, adrenal or pituitary gland problems, heart failure, an irregular heartbeat, increased blood pressure, adrenocortical insufficiency, and hypoglycemia.
Prostate cancer: The prostate gland is a small walnut-sized gland present under the bladder which is responsible for the production of seminal fluid. Prostate cancer is a carcinogenic condition that occurs when the cells of the prostate gland increase out of control. The main cause of this condition is unknown. However, a few underlying reasons that increase the risk for this condition include age, family history, ethnic group, genetic factors, obesity, etc.
Alcohol
Caution
Interaction of Abirakast 250mg Tablet with alcohol is unknown. It is advisable to consult your doctor if you have concerns.
Pregnancy
Not applicable
Not intended for women.
Breast Feeding
Not applicable
Not intended for women.
Driving
Caution
Abirakast 250mg Tablet may decrease alertness or make you feel sleepy and dizzy. So, do not drive or operate heavy machinery while taking Abirakast 250mg Tablet until your vision improves.
Liver
Caution
Abirakast 250mg Tablet should be used with caution, especially if you have a history of liver diseases/conditions. Your doctor may adjust the dose based on your condition.
Kidney
Caution
Abirakast 250mg Tablet should be used with caution, especially if you have a history of kidney diseases/conditions. Your doctor may adjust the dose based on your condition.
Children
Unsafe
Abirakast 250mg Tablet is not recommended for use in children as the safety and efficacy of this medicine are not established.
Country of origin
Product Substitutes